US › Healthcare

iSpecimen Inc (ISPC)

US · Healthcare · Diagnostics & Research

$0.92-10.97%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$151,940

Revenue YoY

-78.7%

Net profit

$-1.4M

EPS

$-0.98

Net margin

-896.9%

Key statistics

Market cap

$2.7M

Forward P/E

0.0

P/B

1.76

Book value

$1.14

EPS (TTM)

$-52.98

52-week high

$36.32

52-week low

$1.02

50-day MA

$1.60

200-day MA

$5.69

Beta

1.65

Analyst view

with an average price target of $3.00.

Shareholding

Institutions

2.58%

Largest institutional holders

Fund	Stake
UBS Group AG	1.27%
Jane Street Group LLC	0.97%
IFP Advisors, LLC	0.33%
Tower Research Capital LLC	0.01%
BlackRock Inc	0.00%
Vanguard Capital Management, LLC	0.00%
Caitong International Asset Management Co., Limited.	0.00%
SBI Securities Co Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for iSpecimen Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.